Boothbay Fund Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-204,456
Closed -$3.05M 1671
2024
Q4
$3.05M Buy
204,456
+173,695
+565% +$2.83M 0.08% 348
2024
Q3
$588K Sell
30,761
-78,908
-72% -$1.64M 0.01% 927
2024
Q2
$2.27M Sell
109,669
-172,636
-61% -$3.43M 0.05% 461
2024
Q1
$5.31M Sell
282,305
-62,891
-18% -$1.08M 0.1% 208
2023
Q4
$4.98M Sell
345,196
-12,111
-3% -$165K 0.13% 197
2023
Q3
$6.2M Buy
357,307
+88,286
+33% +$1.84M 0.15% 158
2023
Q2
$5.6M Buy
269,021
+217,445
+422% +$4.73M 0.12% 187
2023
Q1
$1.21M Buy
+51,576
New +$1.38M 0.02% 916
2022
Q4
Sell
-9,726
Closed -$228K 2326
2022
Q3
$228K Buy
+9,726
New +$294K 0.01% 1727
2021
Q4
Sell
-7,575
Closed -$248K 2120
2021
Q3
$248K Sell
7,575
-428,553
-98% -$13.7M 0.01% 1441
2021
Q2
$13.2M Buy
+436,128
New +$14.4M 0.42% 29

Other funds holding OGN

Boothbay Fund Management's OGN Position: Q1 2025 in Review

Boothbay Fund Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 204,456 shares — an estimated $3.05M sold.

Boothbay Fund Management first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $13.2M in Q2 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Boothbay Fund Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 204,456 Organon & Co shares in Q1 2025, an estimated $3.05M.
  • Boothbay Fund Management first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Boothbay Fund Management's Organon & Co position peaked at $13.2M in Q2 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.